Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The putative
proteasome
-associated proteins Mpa (Mycobaterium proteasomal ATPase) and PafA (
proteasome
accessory factor A) of the human pathogen Mycobacterium tuberculosis (Mtb) are essential for virulence and resistance to nitric oxide. However, a direct link between the
proteasome
protease and Mpa or PafA has never been demonstrated. Furthermore, protein degradation by bacterial proteasomes in vitro has not been accomplished, possibly due to the failure to find natural degradation substrates or other necessary
proteasome
co-factors. In this work, we identify the first bacterial
proteasome
substrates, malonyl Co-A acyl carrier protein transacylase and
ketopantoate hydroxymethyltransferase
, enzymes that are required for the biosynthesis of fatty acids and polyketides that are essential for the pathogenesis of Mtb. Maintenance of the physiological levels of these enzymes required Mpa and PafA in addition to
proteasome
protease activity. Mpa levels were also regulated in a
proteasome
-dependent manner. Finally, we found that a conserved tyrosine of Mpa was essential for function. Thus, these results suggest that Mpa, PafA, and the Mtb
proteasome
degrade bacterial proteins that are important for virulence in mice.
...
PMID:Identification of substrates of the Mycobacterium tuberculosis proteasome. 1708 71